Skip to main content
logo
Enanta Pharmaceuticals, Inc. (ENTA)
NASDAQ: ENTA · Real-Time Price · USD
12.91
+0.26 (2.06%)
At close: Jan 29, 2026, 4:00 PM EST
12.90
-0.01 (-0.08%)
After-hours: Jan 29, 2026, 4:00 PM EST

Enanta Pharmaceuticals Revenue

In the fiscal year ending September 30, 2025, Enanta Pharmaceuticals had annual revenue of $65.32M, down -3.42%. Enanta Pharmaceuticals had revenue of $15.13M in the quarter ending September 30, 2025, with 3.55% growth.

Revenue (ttm)
$65.32M
Revenue Growth
-3.42%
P/S Ratio
4.13
Revenue / Employee
$544,367
Employees
120
Market Cap
372.62M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Sep 30, 202565.32M-2.31M-3.42%
Sep 30, 202467.64M-11.57M-14.61%
Sep 30, 202379.20M-6.96M-8.07%
Sep 30, 202286.16M-10.91M-11.24%
Sep 30, 202197.07M-25.40M-20.74%
Sep 30, 2020122.47M-82.72M-40.31%
Sep 30, 2019205.20M-1.43M-0.69%
Sep 30, 2018206.63M103.81M100.97%
Sep 30, 2017102.81M14.55M16.48%
Sep 30, 201688.27M-72.61M-45.13%
Sep 30, 2015160.88M113.14M236.98%
Sep 30, 201447.74M15.69M48.94%
Sep 30, 201332.05M-9.65M-23.15%
Sep 30, 201241.71M-176.00K-0.42%
Sep 30, 201141.88M19.12M83.99%
Sep 30, 201022.76M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

ENTA News

More News